SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/31/20 Select Medical Holdings Corp 8-K:8,9 3/31/20 11:244K Toppan Merrill/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 30K 2: EX-99.1 Miscellaneous Exhibit HTML 10K 11: R1 Cover HTML 49K 8: XML IDEA XML File -- Filing Summary XML 11K 6: XML XBRL Instance -- tm2014355-1_8k_htm XML 15K 9: EXCEL IDEA Workbook of Financial Reports XLSX 6K 4: EX-101.LAB XBRL Labels -- sem-20200331_lab XML 96K 5: EX-101.PRE XBRL Presentations -- sem-20200331_pre XML 64K 3: EX-101.SCH XBRL Schema -- sem-20200331 XSD 12K 7: JSON XBRL Instance as JSON Data -- MetaLinks 25± 34K 10: ZIP XBRL Zipped Folder -- 0001104659-20-041197-xbrl Zip 12K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
current report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): i March 31, 2020
i SELECT MEDICAL HOLDINGS CORPORATION
(Exact name of registrant as specified in its charter)
i Delaware | i 001-34465 | i 20-1764048 | ||
(State or other jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
i 4714 Gettysburg Road, i P.O. Box 2034
i Mechanicsburg, i PA i 17055
(Address of principal executive offices) (Zip Code)
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
i Common Stock, par value $0.001 per share | i SEM | i New York Stock Exchange (NYSE) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
i ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
i ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
i ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
i ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether either registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if either registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
C:
Item 8.01 | Other Events. |
On March 31, 2020, Select Medical Holdings Corporation (the “Company”) announced a change in the location of the Company’s 2020 Annual Meeting of Stockholders to be held on Tuesday, April 28, 2020 (the “Annual Meeting”). A copy of the press release announcing the location change is attached hereto as Exhibit 99.1 and is incorporated by reference herein. Further information regarding this change to the location of the Annual Meeting can be found in the proxy supplement filed by the Company with the Securities and Exchange Commission on March 31, 2020.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
Exhibit Number | Description |
99.1 | Press Release, dated March 31, 2020, announcing a change in the location of Select Medical Holdings Corporation’s 2020 Annual Meeting of Stockholders. |
104 | The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.
SELECT MEDICAL HOLDINGS CORPORATION | ||
Date: March 31, 2020 | By: | /s/ Michael E. Tarvin |
Michael E. Tarvin | ||
Executive Vice President, General Counsel and Secretary |
C:
C:
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
4/28/20 | 4, 8-K, DEF 14A | |||
Filed on / For Period end: | 3/31/20 | 10-Q, DEFA14A | ||
List all Filings |